• 1

    Yale JF: “Dermatologic and Toenail Disorders,” in Yale’s Podiatric Medicine, ed by JW Pine, p 131, Williams & Wilkins, Baltimore. ,1987. .

  • 2

    Laurent R, Kienzler JL: Epidemiology of HPV infections. .Clin Dermatol 3::64. ,1985. .

  • 3

    Massing AM, Epstein WL: Natural history of warts. .Arch Dermatol 87::306. ,1963. .

  • 4

    Huilgol SC, Barlow RJ, Markey A: Failure of pulsed dye laser therapy for resistant verrucae. .Clin Exp Dermatol 21::93. ,1996. .

  • 5

    Bolton RA: Nongenital warts: classification and treatment options. .Am Fam Physician 43::2049. ,1991. .

  • 6

    Broker TR: Structure and genetic expression of papillomaviruses. .Obstet Gynecol Clin North Am 14::329. ,1987. .

  • 7

    Landsman MJ, Mancuso JE, Abramow SP: Diagnosis, pathophysiology, and treatment of plantar verruca. .Clin Podiatr Med Surg 13::55. ,1996. .

  • 8

    Androphy EJ: Human papillomavirus: current concepts. .Arch Dermatol 125::683. ,1989. .

  • 9

    Cobb MW: Human papillomavirus infection. .J Am Acad Dermatol 22::547. ,1990. .

  • 10

    Almeida JD, Goffe AP: Antibody to wart virus in human sera demonstrated by electron microscopy and precipitin tests. .Lancet 11::1205. ,1965. .

    • Search Google Scholar
    • Export Citation
  • 11

    Ogilvie MM: Serological studies with human wart virus. .J Hyg 68::479. ,1970. .

  • 12

    Genner J: Verrucae vulgares: II. Demonstration of a complement fixation reaction. .Acta Derm Venereol 51::365. ,1971. .

  • 13

    Thivolet J, Viac J, Staquet MJ: Cell-mediated immunity in wart infection. .Int J Dermatol 21::94. ,1982. .

  • 14

    Odom RB, James WD, Berger TG (eds): Andrews’ Diseases of the Skin: Clinical Dermatology, 9th Ed, p 511, WB Saunders, Philadelphia. ,2000. .

  • 15

    Glover MG: Plantar warts. .Foot Ankle 11::172. ,1990. .

  • 16

    Bunney MH, Nolan MW, Williams DA: An assessment of methods of treating viral warts by comparative treatment trials based on a standard design. .Br J Dermatol 94::667. ,1976. .

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 17

    Gross G, Pfister H, Hagedorn M, et al: Correlation between human papillomavirus (HPV) type and histology of warts. .J Invest Dermatol 78::160. ,1982. .

  • 18

    Lapidus PW: Orthopaedic skin lesions of the soles and the toes: calluses, corns, plantar warts, keratomas, neurovascular growths, onychomas. .Clin Orthop Relat Res 45::87. ,1966. .

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 19

    Gibbs RC: Conservative management of plantar warts by gentle chemocautery. .J Dermatol Surg Oncol 4::915. ,1978. .

  • 20

    van Brederode RL, Engel ED: Combined cryotherapy/70% salicylic acid treatment for plantar verrucae. .J Foot Ankle Surg 40::36. ,2001. .

  • 21

    Spanos NP, Williams V, Gwynn MI: Effects of hypnotic, placebo, and salicylic acid treatments on wart regression. .Psychosom Med 52::109. ,1990. .

  • 22

    Luciano CS: Verruca plantaris: a compendium of its understanding and treatment. .JAPA 67::858. ,1977. .

  • 23

    Mroczkowski TF, McEwen C: Warts and other human papillomavirus infections. .Postgrad Med 78::91. ,1985. .

  • 24

    Shelley WB, Shelley ED: Intralesional bleomycin sulfate therapy for warts. .Arch Dermatol 127::234. ,1991. .

  • 25

    Chretien JH, Esswein JG, Garagusi VF: Decreased T cell levels in patients with warts. .Arch Dermatol 114::213. ,1978. .

  • 26

    Morrison WL: In vitro assay of cell-mediated immunity to human wart antigen. .Br J Dermatol 90::531. ,1974. .

  • 27

    Buckner D, Price NM: Immunotherapy of verrucae vulgares with dinitrochlorobenzene. .Br J Dermatol 98::451. ,1978. .

  • 28

    Carter RT: Verruca, some impressions from a study of 118 cases. .JAPA 59::336. ,1969. .

  • 29

    Dagnall J: Monochloroacetic acid and verrucae. .Br J Chiropody 41::105. ,1976. .

  • 30

    Steele K, Shirondaria P, O’Hare M, et al: Monochloroacetic acid and 60% salicylic acid as a treatment for simple plantar warts: effectiveness and mode of action. .Br J Dermatol 118::537. ,1888. .

    • Search Google Scholar
    • Export Citation
  • 31

    Thompson S: The treatment of plantar warts by formaldehyde 10%. .Br J Dermatol 55::267. ,1943. .

  • 32

    Vickers CFH: Treatment of plantar warts in children. .BMJ 5254::743. ,1961. .

  • 33

    Skinner SL, Marks JG: Allergic contact dermatitis to preservatives in topical medicaments. .Am J Contact Dermat 9::199. ,1998. .

  • 34

    Kiec-Swierczynska M, Krysiak B, Kuchowicz E, et al: Occupational allergy to aldehydes in health care workers: clinical observations: experiments. .Int J Occup Med Environ Health 11::349. ,1998. .

    • PubMed
    • Search Google Scholar
    • Export Citation

Treatment for Simple Plantar Verrucae

Monochloroacetic Acid and 10% Formaldehyde versus 10% Formaldehyde Alone

View More View Less
  • 1 Department of Medicine, New York College of Podiatric Medicine, New York, NY. Dr. Jennings is now with the Jennings Institute for Clinical Research in Fort Lee, NJ.
  • | 2 Private practice, Hamilton Square, NJ.
  • | 3 Private practice, Hackensack, NJ.
  • | 4 Private practice, Fair Lawn, NJ.
  • | 5 The Learning Center, New York Medical College, Valhalla.
Restricted access

Verrucae are small, benign, highly vascular epithelial neoplasms that occur singly or in a multiple presentation. Plantar verrucae are usually caused by infection with human papillomavirus types 1, 2, and 4. A clinical trial was conducted to assess the safety and efficacy of monochloroacetic acid and 10% formaldehyde versus 10% formaldehyde alone in the treatment of simple plantar verrucae. Of 57 patients enrolled in the study, 26 were in the monochloroacetic acid and 10% formaldehyde group and 31 were in the 10% formaldehyde alone group. The overall cure rate for this population was 61.4%. There was no statistically significant difference in the cure rate between treatment groups. (J Am Podiatr Med Assoc 96(1): 53–58, 2006)

Corresponding author: Maureen B. Jennings, DPM, Jennings Institute for Clinical Research, 1063 Palisades Ave, Fort Lee, NJ 07024.